Myelodysplastic Syndromes (MDS)

MDS/MPN Overlap

Thumbnail for video Watch Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
David Sallman, MD
In this webinar, Dr. David Sallman discusses the diagnosis of MDS and MPN, treatment options available to patients and symptom management.

2025 AAMDSIF Bone Marrow Failure Summit Myelodysplastic Syndromes Expert Panel

Thumbnail for video Watch Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Olatoyosi Odenike, MD
Mariam Nawas, MD
R. Coleman Lindsley, MD, PhD
Hetty Carraway, M.D.
Salima Benbarche, PhD
Watch MDS experts at the 2025 AAMDSIF Bone Marrow Failure Summit translate and discuss the latest science to advance patient outcomes. This session is moderated by Olatoyosi Odenike, MD from The University of Chicago. Session Topics: Targeting pre-mRNA splicing in MDS – Salima…

Treatment of high-risk myelodysplastic syndromes

Myelodysplastic syndrome (MDS) is considered to be a heterogeneous myeloid malignancy with a common origin in the hematopoietic stem cell compartment and is generally divided into lower- and higher-risk forms. While the treatment goals for lower-risk MDS are to decrease transfusion requirements and transformation into acute leukemia, the major aims for higher-risk MDS are to prolong survival and ultimately cure the patient.

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.